The Interaction of BDNF and NTRK2 Gene Increases the Susceptibility of Paranoid Schizophrenia

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Lin, Zheng ^a   Su, Yousong ^b   Zhang, Chengfang ^b   Xing, Mengjuan ^b   Ding, Wenhua ^b   Liao, Liwei ^b   Guan, Yangtai ^c   Li, Zezhi ^c   Cui, Donghong ^b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR;

ARTICLE; BDNF GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DSM-IV; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NTRK2 GENE; PARANOID SCHIZOPHRENIA; PATHOGENESIS;

ADULT; ALLELES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, TRKB; SCHIZOPHRENIA, PARANOID;

EID: 84884242662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074264     Document Type: Article

References (37)

1. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT, (2006) Neurobiology of schizophrenia. Neuron 52: 139-153.
2. Miyanishi T, Sumiyoshi T, Higuchi Y, Seo T, Suzuki M, (2013) LORETA current source density for duration mismatch negativity and neuropsychological assessment in early schizophrenia.PLoS One. 8: e61152.
3. Buckley PF, Pillai A, Howell KR, (2011) Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry 24: 122-127.
4. Favalli G, Li J, Belmonte-de-Abreu P, Wong AH, Daskalakis ZJ, (2012) The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res 46: 1-11.
5. Pandya CD, Kutiyanawalla A, Pillai A, (2013) BDNF-TrkB signaling and neuroprotection in schizophrenia. Asian J Psychiatr 6: 22-28.
6. Lu W, Zhang C, Yi Z, Li Z, Wu Z, et al. (2012) Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia. J Mol Neurosci 47: 505-510.
7. Zhang XY, Liang J, Chen da C, Xiu MH, Yang FD, et al. (2012) Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology (Berl) 222: 277-284.
8. Lee AH, Lange C, Ricken R, Hellweg R, Lang UE, (2011) Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment. J Clin Psychopharmacol 31: 334-336.
9. Issa G, Wilson C, Terry AV Jr, Pillai A, (2010) An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiology of Disease 39: 327-333.
10. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, et al. (2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Molecular Psychiatry 8 (6): 592-610.
11. Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, et al. (1991) trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65: 885-893.
12. Weickert CS, Ligons DL, Romanczyk T, Ungaro G, Hyde TM, et al. (2005) Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry 10: 637-650.
13. Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, et al. (2005) Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia. The Journal of Neuroscience 25: 372-383.
14. Thompson Ray M, Weickert CS, Wyatt E, Webster MJ, (2011) Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 36: 195-203.
15. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
16. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, et al. (2004) The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24: 10099-10102.
17. Muglia P, Vicente AM, Verga M, King N, Macciardi F, et al. (2003) Association between the BDNF gene and schizophrenia. Mol. Psychiatry 8: 146-147.
18. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, et al. (2005) BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 10: 208-212.
19. Sun MM, Yang LM, Wang Y, Feng X, Cui KY, et al. (2013) BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population. Psychiatr Genet [Epub ahead of print].
20. Gratacòs M, González JR, Mercader JM, de Cid R, Urretavizcaya M, et al. (2007) Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 61: 911-922.
21. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT, (2007) Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatry Genet 17: 165-170.
22. Xu MQ, St Clair D, Ott J, Feng GY, He L, (2007) Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr Res 91: 6-13.
23. Bremer T, Diamond C, McKinney R, Shehktman T, Barrett TB, et al. (2007) The pharmacogenetics of lithium response depends upon clinical co-morbidity. Mol Diagn Ther 11: 161-170.
24. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, et al. (2009) Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14: 755-763.
25. Wang Z, Li Z, Gao K, Fan J, Wang L, et al. (2012) Association of BDNF Gene Polymorphism with Bipolar Disorder in Han Chinese Population. Genes Brain Behav 11: 524-528.
26. Li Z, Zhang Y, Wang Z, Chen J, Fan J, et al. (2013) The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: Data from multicenter, prospective, longitudinal clinic practice. J Psychiatr Res 47: 8-14.
27. Zhang C, Li Z, Shao Y, Xie B, Du Y, et al. (2011) Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. J Mol Neurosci 43: 406-411.
28. Burmeister M, McInnis MG, Zollner S, (2008) Psychiatric genetics: progress amid controversy. Nat Rev Genet 9: 527-540.
29. Gauderman WJ, Morrison JM (2006) QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra.usc.edu/gxe. Accessed 2009 May.
30. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, et al. (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69: 138-147.
31. Dervieux T, Wessels JA, Kremer JM, Padyukov L, Seddighzadeh M, et al. (2012) Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis. Pharmacogenet Genomics 22: 1-9.
32. Wang Y, Wang JD, Wu HR, Zhang BS, Fang H, et al. (2010) The Val66Met polymorphism of the brain-derived neurotrophic factor gene is not associated with risk for schizophrenia and tardive dyskinesia in Han Chinese population. Schizophr Res 120: 240-242.
33. Sun RF, Zhu YS, Kuang WJ, Liu Y, Li SB, (2011) The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia. Neurosci Lett 489: 34-37.
34. Zhang XY, Chen da C, Xiu MH, Haile CN, Luo X, et al. (2012) Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum Genet 131: 1187-1195.
35. Yi Z, Zhang C, Wu Z, Hong W, Li Z, et al. (2011) Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population. Brain Res 1417: 146-150.
36. Suchanek R, Owczarek A, Paul-Samojedny M, Kowalczyk M, Kucia K, et al. (2013) BDNF val66met polymorphism is associated with age at onset and intensity of symptoms of paranoid schizophrenia in a Polish population. J Neuropsychiatry Clin Neurosci 25: 88-94.
37. Kawanishi Y, Harada S, Tachikawa H, Okubo T, Shiraishi H, (1999) Novel variants in the promoter region of the CREB gene in schizophrenic patients. J Hum Genet 44: 428-430.